Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ViperCath XC Peripheral Exchange Catheter

K-Number: K183000 · 2018-12-29

Decision Date2018-12-29
Product CodeDQY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ViperCath XC Peripheral Exchange Catheter is a medical device manufactured by Cardiovascular Systems, Inc.. It received FDA 510(k) clearance on 2018-12-29 under approval number K183000. The device is classified under product code DQY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ViperCath XC Peripheral Exchange Catheter?

ViperCath XC Peripheral Exchange Catheter is a medical device that received FDA 510(k) clearance on 2018-12-29. It is manufactured by Cardiovascular Systems, Inc.. The 510(k) number is K183000.

When was ViperCath XC Peripheral Exchange Catheter approved by the FDA?

ViperCath XC Peripheral Exchange Catheter received FDA 510(k) clearance on 2018-12-29, under approval number K183000.

What company makes ViperCath XC Peripheral Exchange Catheter?

ViperCath XC Peripheral Exchange Catheter is manufactured by Cardiovascular Systems, Inc..

What is the FDA product code for ViperCath XC Peripheral Exchange Catheter?

The FDA product code for ViperCath XC Peripheral Exchange Catheter is DQY.

Related Clinical Trials

Other Devices by Cardiovascular Systems, Inc.

View all 14 devices →

Related Devices (Code: DQY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.